Michael de Kok

Mr. Michael de Kok

Molecular Cell and Biology
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Cytometry Part A
Verified
Journal Article
Open access
JRJanna E. G. Roet
Janna E. G. Roet
AMAleksandra M. Mikula
Aleksandra M. Mikula
Michael de KokMichael de Kok
Michael de Kok
CCCora H. Chadick
Cora H. Chadick
JVJuan J. Garcia Vallejo
Juan J. Garcia Vallejo
RMReina E. Mebius
Reina E. Mebius
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by photo‐excitatory molecular content, which can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and, even within one cell type, heterogeneity of autofluorescence spectra can be present, for example, as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of photo detectors across a range of wavelengths, creating an unique signature for that fluorochrome. This signature is then used to identify, or unmix, that fluorochrome's unique spectrum from a multicolor sample containing different fluorescent molecules. Importantly, this means that this technology can also be used to identify intrinsic autofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has a singular, relatively homogeneous and bright autofluorescence spectrum. To analyze samples with heterogeneous autofluorescence spectral profiles, we setup an unbiased workflow to more quickly identify differing autofluorescence spectra present in a sample to include as “autofluorescence signatures” during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering of unstained cells. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. Independent of the intensity of the autofluorescence and immunophenotyping of cell subsets, this unbiased method allows for the identification of most of the distinct autofluorescence spectra present in a sample, leading to less confounding autofluorescence spillover and spread into extrinsic phenotyping markers. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells, and in vitro cultures of (primary) cells.

10 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
ABAthanasios Blanas
Athanasios Blanas
AZAnouk Zaal
Anouk Zaal
IÀIrene van der Haar Àvila
Irene van der Haar Àvila
Maxime KempersMaxime Kempers
Maxime Kempers
LKLaura Kruijssen
Laura Kruijssen
Sandra J. Van VlietSandra J. Van Vliet
Sandra J. Van Vliet
Cancer stem cells (CSCs) are located in dedicated niches, where they remain inert to chemotherapeutic drugs and drive metastasis. Although plasticity in the CSC pool is well appreciated, the molecular mechanisms implicated in the regulation of cancer stemness are still elusive. Here, we define a fucosylation-dependent reprogramming of colon cancer cells towards a stem cell-like phenotype and function. De novo transcriptional activation of Fut9 in the murine colon adenocarcinoma cell line, MC38, followed by RNA seq-based regulon analysis, revealed major gene regulatory networks related to stemness. Lewisx, Sox2, ALDH and CD44 expression, tumorsphere formation, resistance to 5-FU treatment and in vivo tumor growth were increased in FUT9-expressing MC38 cells compared to the control cells. Likewise, human CRC cell lines highly expressing FUT9 displayed phenotypic features of CSCs, which were significantly impaired upon FUT9 knock-out. Finally, in primary CRC FUT9+ tumor cells pathways related to cancer stemness were enriched, providing a clinically meaningful annotation of the complicity of FUT9 in stemness regulation and may open new avenues for therapeutic intervention.

19 December 2023 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
AMAndrew I. Morrison
Andrew I. Morrison
AMAleksandra M. Mikula
Aleksandra M. Mikula
SSs w spiekstra
s w spiekstra
Michael de KokMichael de Kok
Michael de Kok
AAAlsya Affandi
Alsya Affandi
RMReina E. Mebius
Reina E. Mebius

16 November 2025 in The FEBS Journal
Verified
Journal Article
Open access
NMNadia L. van der Meijs
Nadia L. van der Meijs
RHRemi Hatinguais
Remi Hatinguais
Michael de KokMichael de Kok
Michael de Kok
RLR. J. Eveline Li
R. J. Eveline Li
TGTesfay M. Godefa
Tesfay M. Godefa
Sandra J. Van VlietSandra J. Van Vliet
Sandra J. Van Vliet
C‐type lectin receptors on dendritic cells shape immune responses to pathogens and tumour cells through the specific recognition of glycans. C‐type lectin domain family 10 member A [CLEC10A; also known as Macrophage Galactose‐type Lectin (MGL)] binds terminal N ‐acetylgalactosamine (GalNAc) residues, which are often highly exposed on tumours. Signalling through this receptor increases Interleukin‐10 (IL‐10) and Tumour Necrosis Factor alpha (TNFα) production by monocyte‐derived dendritic cells (moDCs), which promotes a T helper 2 (Th2) or type 1 regulatory T‐cell (Tr1) response. Recently, several CLEC10A glycan ligands were identified that induce distinct conformational changes in the CLEC10A carbohydrate recognition domain, but their ability to alter moDC function has not been thoroughly explored. Here, we used CLEC10A ligand glycodendrimers to investigate the transcriptional responses induced by the CLEC10A ligands previously modelled and determined how these transcriptional programmes were associated with the cellular moDC responses. The CLEC10A ligand dendrimers varied in their affinity for CLEC10A and their capacity to increase IL‐10 produced by moDCs. Although all glycodendrimers induced differential gene expression, this was strongest for the Forssman antigen dendrimer. The gene ontology (GO) terms associated with genes detected across ligands related to mitogen‐activated protein kinase (MAPK) signalling, chemotaxis, apoptosis, angiogenesis, cytokine production and CD4 + T‐cell differentiation. The CLEC10A ligand dendrimers also altered the chemokine profile secreted by moDCs. Furthermore, these glycodendrimers increased the percentage of C‐C Chemokine Receptor type 7 (CCR7)‐expressing moDCs, which was prevented by inhibiting CLEC10A signalling. Overall, there was limited evidence for glycan‐specific signalling via CLEC10A, but the glycans did alter the magnitude of the CLEC10A‐mediated responses.

29 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JRJanna E.G. Roet
Janna E.G. Roet
AMAleksandra M. Mikula
Aleksandra M. Mikula
Michael de KokMichael de Kok
Michael de Kok
CCCora H. Chadick
Cora H. Chadick
JVJuan J. Garcia Vallejo
Juan J. Garcia Vallejo
RMReina E. Mebius
Reina E. Mebius
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by its cellular content, that can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and even within one cell type heterogeneity of autofluorescence spectra can be present, for example as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of detectors across a range of wavelengths, creating an unique spectrum for this fluorochrome, that is used to unmix the signal of a full stained sample into the signals of the different fluorochromes. Importantly, this technology can also be used to identify the aut-ofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has one homogeneous autofluorescence spectrum. To analyze samples with a heterogeneous autofluorescence spectral profile, we here setup an unbiased workflow to detect all different autofluorescence spectra present in a sample to take them along as ‘autofluorescence signatures’ during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. This unbiased method allows for the identification of all autofluorescence spectra present in a sample, independent of cell types and intensity of the autofluorescence spectra. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells and in vitro cultures of (primary) cells.